|
|
News Breaks
|
October 6, 2009
|
| 07:01 EDT |  | VRUS |
| theflyonthewall.com: | Pharmasset nominates PSI-879 as development candidate | | Pharmasset announced the nomination of PSI-352879, or PSI-879, as a second development candidate from two series of purine analogs for the treatment of chronic hepatitis C virus infection. PSI-879 is a proprietary nucleotide analog polymerase inhibitor of HCV that is being advanced into studies required for submission of an Investigational New Drug application with the FDA or equivalent foreign regulatory application. :theflyonthewall.com |
|
|
News For VRUS From The Last 14 Days Check below for free stories on VRUS the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
